ID   SL9A3_RAT               Reviewed;         831 AA.
AC   P26433;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2023, sequence version 2.
DT   02-OCT-2024, entry version 167.
DE   RecName: Full=Sodium/hydrogen exchanger 3;
DE   AltName: Full=Na(+)/H(+) exchanger 3;
DE            Short=NHE-3;
DE   AltName: Full=Solute carrier family 9 member 3;
DE   Flags: Precursor;
GN   Name=Slc9a3; Synonyms=Nhe3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=1577762; DOI=10.1016/s0021-9258(19)50428-8;
RA   Orlowski J., Kandasamy R.A., Shull G.E.;
RT   "Molecular cloning of putative members of the Na/H exchanger gene family.
RT   cDNA cloning, deduced amino acid sequence, and mRNA tissue expression of
RT   the rat Na/H exchanger NHE-1 and two structurally related proteins.";
RL   J. Biol. Chem. 267:9331-9339(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8393860; DOI=10.1016/s0021-9258(19)85430-3;
RA   Orlowski J.;
RT   "Heterologous expression and functional properties of amiloride high
RT   affinity (NHE-1) and low affinity (NHE-3) isoforms of the rat Na/H
RT   exchanger.";
RL   J. Biol. Chem. 268:16369-16377(1993).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9442041; DOI=10.1074/jbc.273.4.2035;
RA   D'Souza S., Garcia-Cabado A., Yu F., Teter K., Lukacs G., Skorecki K.,
RA   Moore H.P., Orlowski J., Grinstein S.;
RT   "The epithelial sodium-hydrogen antiporter Na+/H+ exchanger 3 accumulates
RT   and is functional in recycling endosomes.";
RL   J. Biol. Chem. 273:2035-2043(1998).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, PHOSPHORYLATION AT SER-552 AND SER-605, AND
RP   ACTIVITY REGULATION.
RX   PubMed=9933588; DOI=10.1074/jbc.274.7.3978;
RA   Zhao H., Wiederkehr M.R., Fan L., Collazo R.L., Crowder L.A., Moe O.W.;
RT   "Acute inhibition of Na/H exchanger NHE-3 by cAMP. Role of protein kinase a
RT   and NHE-3 phosphoserines 552 and 605.";
RL   J. Biol. Chem. 274:3978-3987(1999).
RN   [6]
RP   INTERACTION WITH CHP1 AND CHP2.
RX   PubMed=12576672; DOI=10.1248/bpb.26.148;
RA   Inoue H., Nakamura Y., Nagita M., Takai T., Masuda M., Nakamura N.,
RA   Kanazawa H.;
RT   "Calcineurin homologous protein isoform 2 (CHP2), Na+/H+ exchangers-binding
RT   protein, is expressed in intestinal epithelium.";
RL   Biol. Pharm. Bull. 26:148-155(2003).
RN   [7]
RP   INTERACTION WITH SHANK2.
RX   PubMed=16293618; DOI=10.1074/jbc.m509786200;
RA   Han W., Kim K.H., Jo M.J., Lee J.H., Yang J., Doctor R.B., Moe O.W.,
RA   Lee J., Kim E., Lee M.G.;
RT   "Shank2 associates with and regulates Na+/H+ exchanger 3.";
RL   J. Biol. Chem. 281:1461-1469(2006).
RN   [8]
RP   TISSUE SPECIFICITY, INTERACTION WITH AHCYL1, AND SUBCELLULAR LOCATION.
RX   PubMed=20584908; DOI=10.1074/jbc.m110.133066;
RA   He P., Klein J., Yun C.C.;
RT   "Activation of Na+/H+ exchanger NHE3 by angiotensin II is mediated by
RT   inositol 1,4,5-triphosphate (IP3) receptor-binding protein released with
RT   IP3 (IRBIT) and Ca2+/calmodulin-dependent protein kinase II.";
RL   J. Biol. Chem. 285:27869-27878(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-552; SER-560 AND SER-807, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Plasma membrane Na(+)/H(+) antiporter. Exchanges
CC       intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry,
CC       playing a key role in salt and fluid absorption and pH homeostasis
CC       (PubMed:8393860, PubMed:9442041). Major apical Na(+)/H(+) exchanger in
CC       kidney and intestine playing an important role in renal and intestine
CC       Na(+) absorption and blood pressure regulation (By similarity).
CC       {ECO:0000250|UniProtKB:P48764, ECO:0000269|PubMed:8393860,
CC       ECO:0000269|PubMed:9442041}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(out) + Na(+)(in) = H(+)(in) + Na(+)(out);
CC         Xref=Rhea:RHEA:29419, ChEBI:CHEBI:15378, ChEBI:CHEBI:29101;
CC         Evidence={ECO:0000269|PubMed:8393860, ECO:0000269|PubMed:9442041,
CC         ECO:0000269|PubMed:9933588};
CC   -!- ACTIVITY REGULATION: Seems to switch between active and inactive modes
CC       in response to various stimuli (By similarity). Activated directly or
CC       indirectly by membrane phosphatidylinositol (PIs) (By similarity).
CC       Regulated by a variety of auxiliary proteins, which facilitate the
CC       maturation, cell surface expression and function of the transporter.
CC       Inhibited specifically by the drug tenapanor (By similarity).
CC       {ECO:0000250|UniProtKB:P26432, ECO:0000250|UniProtKB:P48764}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.7 mM for Na(+) {ECO:0000269|PubMed:8393860};
CC   -!- SUBUNIT: Homodimer (By similarity). Found in the forms of complex and
CC       dynamic macromolecular complexes (By similarity). Binds NHERF1 and
CC       NHERF2 (By similarity). Interacts with NHERF4 and interactions decrease
CC       in response to elevated calcium ion levels (By similarity). Interacts
CC       with PDZK1 (via C-terminal PDZ domain) (By similarity). Interacts with
CC       CHP1; this interaction increases trafficking and activity at the plasma
CC       membrane of SLC9A3 (By similarity) (PubMed:12576672). Interacts with
CC       CHP2 and SHANK2 (PubMed:12576672, PubMed:16293618). Interacts with
CC       AHCYL1; the interaction is required for SLC9A3 activity
CC       (PubMed:20584908). Interacts with EZR; interaction targets SLC9A3 to
CC       the apical membrane (By similarity). Interacts with SNX27 (via PDZ
CC       domains); directs SLC9A3 membrane insertion from early endosomes to the
CC       plasma membrane (By similarity). {ECO:0000250|UniProtKB:P26432,
CC       ECO:0000250|UniProtKB:P48764, ECO:0000250|UniProtKB:Q28362,
CC       ECO:0000269|PubMed:12576672, ECO:0000269|PubMed:16293618,
CC       ECO:0000269|PubMed:20584908}.
CC   -!- INTERACTION:
CC       P26433; O55043: Arhgef7; NbExp=3; IntAct=EBI-961694, EBI-3649585;
CC       P26433; Q810D1: Chp2; NbExp=3; IntAct=EBI-961694, EBI-6146708;
CC       P26433; Q9QX74: Shank2; NbExp=5; IntAct=EBI-961694, EBI-397902;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:20584908}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P48764}. Cell membrane
CC       {ECO:0000250|UniProtKB:P48764}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P48764}. Recycling endosome membrane
CC       {ECO:0000269|PubMed:9442041}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P48764}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:P48764}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P48764}. Note=In intestinal epithelial cells,
CC       localizes to the ileal brush border. Angiotensin-2 enhances apical
CC       expression (By similarity). Translocates between intracellular
CC       compartments and the plasma membrane via a clathrin-mediated pathway
CC       (PubMed:9442041). {ECO:0000250|UniProtKB:Q28362,
CC       ECO:0000269|PubMed:9442041}.
CC   -!- TISSUE SPECIFICITY: Most abundant in colon and small intestine,
CC       followed by kidney and stomach. In kidney, expressed in proximal
CC       tubules and outer medulla (at protein level).
CC       {ECO:0000269|PubMed:1577762, ECO:0000269|PubMed:20584908}.
CC   -!- DOMAIN: The C-terminal intracellular domain is subject to extensive
CC       post-translational modifications and binding partner interactions which
CC       regulate transporter activity, scaffolding functions, downstream events
CC       and localization. {ECO:0000269|PubMed:12576672,
CC       ECO:0000269|PubMed:16293618, ECO:0000269|PubMed:20584908,
CC       ECO:0000269|PubMed:9933588}.
CC   -!- PTM: Phosphorylated by PRKACA at Ser-552 and Ser-605, which inhibits
CC       activity (PubMed:9933588). Phosphorylation of Ser-605 is essential for
CC       cAMP-mediated inhibition of SLC9A3 (PubMed:9933588). Phosphorylation at
CC       Ser-661 by SGK1 is associated with increased abundance at the cell
CC       membrane (By similarity). Phosphorylation at Ser-716 by CSNK2A1
CC       regulates SLC9A3 activity through the formation of multiple signaling
CC       complexes (By similarity). {ECO:0000250|UniProtKB:P26432,
CC       ECO:0000269|PubMed:9933588}.
CC   -!- SIMILARITY: Belongs to the monovalent cation:p,roton antiporter 1
CC       (CPA1) transporter (TC 2.A.36) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M85300; AAA41702.1; -; mRNA.
DR   EMBL; AC094921; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; B40204; B40204.
DR   RefSeq; NP_036786.1; NM_012654.1.
DR   RefSeq; XP_008756899.1; XM_008758677.2.
DR   AlphaFoldDB; P26433; -.
DR   SMR; P26433; -.
DR   BioGRID; 246908; 1.
DR   IntAct; P26433; 7.
DR   MINT; P26433; -.
DR   STRING; 10116.ENSRNOP00000020711; -.
DR   BindingDB; P26433; -.
DR   ChEMBL; CHEMBL3879842; -.
DR   DrugCentral; P26433; -.
DR   GuidetoPHARMACOLOGY; 950; -.
DR   TCDB; 2.A.36.1.2; the monovalent cation:proton antiporter-1 (cpa1) family.
DR   GlyCosmos; P26433; 1 site, No reported glycans.
DR   iPTMnet; P26433; -.
DR   PhosphoSitePlus; P26433; -.
DR   PaxDb; 10116-ENSRNOP00000020711; -.
DR   DNASU; 24784; -.
DR   Ensembl; ENSRNOT00000020711.4; ENSRNOP00000020711.2; ENSRNOG00000015159.6.
DR   GeneID; 24784; -.
DR   KEGG; rno:24784; -.
DR   UCSC; RGD:3720; rat.
DR   AGR; RGD:3720; -.
DR   CTD; 6550; -.
DR   RGD; 3720; Slc9a3.
DR   eggNOG; KOG1966; Eukaryota.
DR   GeneTree; ENSGT00940000158616; -.
DR   HOGENOM; CLU_005912_4_2_1; -.
DR   InParanoid; P26433; -.
DR   OMA; TGTECVK; -.
DR   OrthoDB; 389547at2759; -.
DR   PhylomeDB; P26433; -.
DR   TreeFam; TF317212; -.
DR   Reactome; R-RNO-425986; Sodium/Proton exchangers.
DR   PRO; PR:P26433; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IDA:RGD.
DR   GO; GO:0031526; C:brush border membrane; IDA:RGD.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0015386; F:potassium:proton antiporter activity; IBA:GO_Central.
DR   GO; GO:0015385; F:sodium:proton antiporter activity; IDA:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:1902600; P:proton transmembrane transport; ISO:RGD.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IMP:RGD.
DR   GO; GO:0051453; P:regulation of intracellular pH; ISO:RGD.
DR   GO; GO:0006885; P:regulation of pH; IDA:RGD.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IMP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0098719; P:sodium ion import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006814; P:sodium ion transport; IDA:RGD.
DR   Gene3D; 6.10.140.1330; -; 1.
DR   InterPro; IPR006153; Cation/H_exchanger.
DR   InterPro; IPR018422; Cation/H_exchanger_CPA1.
DR   InterPro; IPR018410; Na/H_exchanger_3/5.
DR   InterPro; IPR004709; NaH_exchanger.
DR   NCBIfam; TIGR00840; b_cpa1; 1.
DR   PANTHER; PTHR10110; SODIUM/HYDROGEN EXCHANGER; 1.
DR   PANTHER; PTHR10110:SF90; SODIUM_HYDROGEN EXCHANGER 3; 1.
DR   Pfam; PF00999; Na_H_Exchanger; 1.
DR   PRINTS; PR01084; NAHEXCHNGR.
DR   PRINTS; PR01087; NAHEXCHNGR3.
PE   1: Evidence at protein level;
KW   Antiport; Cell membrane; Endosome; Ion transport; Membrane; Phosphoprotein;
KW   Reference proteome; Signal; Sodium; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..831
FT                   /note="Sodium/hydrogen exchanger 3"
FT                   /id="PRO_0000052358"
FT   TOPO_DOM        29..48
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        49..71
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        72..79
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        80..99
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        100..108
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        109..126
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        127..129
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        130..165
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        166..178
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        179..200
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        201..202
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        203..234
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        235..241
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        242..276
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        277..278
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        279..301
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        302..303
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        304..320
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        321..327
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        328..356
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        357..364
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        365..386
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        387..399
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        400..423
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        424..430
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        431..464
FT                   /note="Helical; Name=13"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   TOPO_DOM        465..831
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          573..587
FT                   /note="Interaction with EZR"
FT                   /evidence="ECO:0000250|UniProtKB:P26432"
FT   REGION          588..665
FT                   /note="Interaction with NHERF4"
FT                   /evidence="ECO:0000250|UniProtKB:P26432"
FT   REGION          589..693
FT                   /note="Interaction with AHCYL1"
FT                   /evidence="ECO:0000250|UniProtKB:P26432"
FT   REGION          808..831
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         135
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   BINDING         138
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   BINDING         139
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   BINDING         395
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   BINDING         494
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   BINDING         495
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   BINDING         497
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:P48764"
FT   MOD_RES         552
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9933588,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         560
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         590
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G3X939"
FT   MOD_RES         605
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9933588"
FT   MOD_RES         661
FT                   /note="Phosphoserine; by SGK1"
FT                   /evidence="ECO:0000250|UniProtKB:P26432"
FT   MOD_RES         716
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26432"
FT   MOD_RES         807
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         810
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:G3X939"
FT   CONFLICT        18..20
FT                   /note="LAL -> VAV (in Ref. 1; AAA41702)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   831 AA;  93133 MW;  58B049738CF88018 CRC64;
     MWHPALGPGW KPLLALALAL TSLRGVRGIE EEPNSGGSFQ IVTFKWHHVQ DPYIIALWIL
     VASLAKIVFH LSHKVTSVVP ESALLIVLGL VLGGIVWAAD HIASFTLTPT LFFFYLLPPI
     VLDAGYFMPN RLFFGNLGTI LLYAVIGTIW NAATTGLSLY GVFLSGLMGE LKIGLLDFLL
     FGSLIAAVDP VAVLAVFEEV HVNEVLFIIV FGESLLNDAV TVVLYNVFES FVTLGGDAVT
     GVDCVKGIVS FFVVSLGGTL VGVIFAFLLS LVTRFTKHVR IIEPGFVFVI SYLSYLTSEM
     LSLSAILAIT FCGICCQKYV KANISEQSAT TVRYTMKMLA SGAETIIFMF LGISAVDPVI
     WTWNTAFVLL TLVFISVYRA IGVVLQTWIL NRYRMVQLET IDQVVMSYGG LRGAVAYALV
     VLLDEKKVKE KNLFVSTTLI VVFFTVIFQG LTIKPLVQWL KVKRSEQREP KLNEKLHGRA
     FDHILSAIED ISGQIGHNYL RDKWSNFDRK FLSKVLMRRS AQKSRDRILN VFHELNLKDA
     ISYVAEGERR GSLAFIRSPS TDNMVNVDFS TPRPSTVEAS VSYFLRENVS AVCLDMQSLE
     QRRRSIRDTE DMVTHHTLQQ YLYKPRQEYK HLYSRHELTP NEDEKQDKEI FHRTMRKRLE
     SFKSAKLGIN QNKKAAKLYK RERAQKRRNS SIPNGKLPME NLAHNFTIKE KDLELSEPEE
     ATNYEEISGG IEFLASVTKD VASDSGAGID NPVFSPDEDL DPSILSRVPP WLSPGETVVP
     SQRARVQIPN SPSNFRRLTP FRLSNKSVDS FLQADGPEEQ LQPASPESTH M
//
